[PHAS] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
14-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -23.39%
YoY- -44.17%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 703 320 764 241 703 653 257 95.71%
PBT -28,142 -14,905 -11,331 -11,391 -9,232 -7,293 -4,868 222.45%
Tax -3,665 -239 314 465 469 317 2,975 -
NP -28,142 -14,905 -11,331 -11,391 -9,232 -7,293 -4,868 222.45%
Tax Rate - - - - - - - -
Total Cost 28,845 15,225 12,095 11,632 9,935 7,946 5,125 216.74%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -4,003.13 -4,657.81 -1,483.12 -4,726.56 -1,313.23 -1,116.85 -1,894.16 64.76%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.98 -0.52 -0.39 -0.40 -0.33 -0.30 -0.26 142.39%
EPS Diluted -0.98 -0.52 -0.39 -0.40 -0.33 -0.30 -0.26 142.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.